Rahala Begum

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Chicago Zoological Society, Inc. provides animal care services. It provides indoor animal exhibition, family play zoo, dolphin presentations, and motor safari tram tours. The firm offers programming for various groups, including teachers, schools, youth groups, groups with disabilities, community groups, and teens, as well as individuals, families, and children. The company was founded in 1934 and is headquartered in Brookfield, IL.

Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples.

Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom.

Pencil Biosciences Ltd. develops gene modulation technology. The company was founded on November 5, 2018 and is headquartered in Macclesfield, the United Kingdom.

Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.